Avanos Medical, Inc. (AVNS)Healthcare | Medical Devices | Alpharetta, United States | NYSE
24.62 USD
-0.04
(-0.162%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 24.49 -0.13 (-0.130%) ⇩ (April 17, 2026, 6:18 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 3:59 p.m. EDT
AVNS shows a mixed outlook. The recent price action has been relatively stable, with some fluctuations but overall trending upward. However, the company is currently unprofitable, with negative profit margins and a low forward EPS. The lack of dividends makes it unsuitable for income-focused investors. While there is some institutional buying and insider activity, the overall fundamentals are weak, and the high debt-to-equity ratio suggests financial risk. Short-term traders might consider the recent price movements and the options activity, but the long-term outlook is cautious due to the company's financial health and lack of consistent earnings. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.073440 |
| MSTL | 0.096734 |
| AutoARIMA | 0.098285 |
| AutoETS | 0.098303 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 10% |
| H-stat | 9.08 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 7.14 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 16.59 |
| Revenue per Share | 15.145 |
| Market Cap | 1,149,118,208 |
| Forward P/E | 19.70 |
| Beta | 1.05 |
| Profit Margins | -10.40% |
| Website | https://avanos.com |
As of April 11, 2026, 3:59 p.m. EDT: Options speculators are showing mixed signals. For the April 17 expiration, there is significant open interest (OI) in call options around the $12.5 strike, which is slightly below the current price, indicating some bullish sentiment. However, there is very little put activity, suggesting limited bearish positioning. For the July 17 expiration, there is a similar pattern with OI in call options at the $12.5 strike, but again, minimal put activity. For the October 16 expiration, there is a slight increase in put OI, which could indicate some caution, but the overall options activity remains low. The ATM IV for the October 16 expiration is higher, suggesting increased volatility expectations for the longer-term. Overall, the options market is not providing strong signals about a clear directional move.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.0380795 |
| Address1 | 5,405 Windward Parkway |
| Address2 | Suite 100 South |
| All Time High | 72.96 |
| All Time Low | 9.303 |
| Ask | 24.65 |
| Ask Size | 2,700 |
| Audit Risk | 8 |
| Average Analyst Rating | 3.0 - Hold |
| Average Daily Volume10 Day | 3,648,980 |
| Average Daily Volume3 Month | 1,085,962 |
| Average Volume | 1,085,962 |
| Average Volume10Days | 3,648,980 |
| Beta | 1.05 |
| Bid | 24.63 |
| Bid Size | 2,400 |
| Board Risk | 1 |
| Book Value | 16.751 |
| City | Alpharetta |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 3 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 24.62 |
| Current Ratio | 2.151 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 24.65 |
| Day Low | 24.61 |
| Debt To Equity | 16.59 |
| Display Name | Avanos Medical |
| Earnings Call Timestamp End | 1,771,941,600 |
| Earnings Call Timestamp Start | 1,771,941,600 |
| Earnings Timestamp | 1,771,939,800 |
| Earnings Timestamp End | 1,778,502,600 |
| Earnings Timestamp Start | 1,778,502,600 |
| Ebitda | 54,400,000 |
| Ebitda Margins | 0.07758 |
| Enterprise To Ebitda | 21.769 |
| Enterprise To Revenue | 1.689 |
| Enterprise Value | 1,184,215,168 |
| Eps Current Year | 1.0 |
| Eps Forward | 1.25 |
| Eps Trailing Twelve Months | -1.57 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 14.8948 |
| Fifty Day Average Change | 9.725201 |
| Fifty Day Average Change Percent | 0.6529259 |
| Fifty Two Week Change Percent | 103.80795 |
| Fifty Two Week High | 24.72 |
| Fifty Two Week High Change | -0.099998474 |
| Fifty Two Week High Change Percent | -0.0040452457 |
| Fifty Two Week Low | 9.303 |
| Fifty Two Week Low Change | 15.317 |
| Fifty Two Week Low Change Percent | 1.6464581 |
| Fifty Two Week Range | 9.303 - 24.72 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,413,898,200,000 |
| Float Shares | 42,008,434 |
| Forward Eps | 1.25 |
| Forward P E | 19.696001 |
| Free Cashflow | 46,012,500 |
| Full Exchange Name | NYSE |
| Full Time Employees | 2,287 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.50471 |
| Gross Profits | 353,900,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.047859997 |
| Held Percent Institutions | 0.98793 |
| Implied Shares Outstanding | 46,674,172 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia. |
| Long Name | Avanos Medical, Inc. |
| Market | us_market |
| Market Cap | 1,149,118,208 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_251719973 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -72,900,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,149,118,114 |
| Open | 24.62 |
| Operating Cashflow | 74,700,000 |
| Operating Margins | 0.0199 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Phone | 844 428 2667 |
| Post Market Change | -0.13000107 |
| Post Market Change Percent | -0.52803034 |
| Post Market Price | 24.49 |
| Post Market Time | 1,776,464,281 |
| Previous Close | 24.66 |
| Price Eps Current Year | 24.62 |
| Price Hint | 2 |
| Price To Book | 1.469763 |
| Price To Sales Trailing12 Months | 1.6387881 |
| Profit Margins | -0.10396 |
| Quick Ratio | 1.172 |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Region | US |
| Regular Market Change | -0.039999 |
| Regular Market Change Percent | -0.162202 |
| Regular Market Day High | 24.65 |
| Regular Market Day Low | 24.61 |
| Regular Market Day Range | 24.61 - 24.65 |
| Regular Market Open | 24.62 |
| Regular Market Previous Close | 24.66 |
| Regular Market Price | 24.62 |
| Regular Market Time | 1,776,456,014 |
| Regular Market Volume | 1,333,826 |
| Return On Assets | 0.0087 |
| Return On Equity | -0.09075 |
| Revenue Growth | 0.007 |
| Revenue Per Share | 15.145 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 46,674,172 |
| Shares Percent Shares Out | 0.0466 |
| Shares Short | 2,168,244 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,607,300 |
| Short Name | Avanos Medical, Inc. |
| Short Percent Of Float | 0.0625 |
| Short Ratio | 3.75 |
| Source Interval | 15 |
| State | GA |
| Symbol | AVNS |
| Total Cash | 89,800,000 |
| Total Cash Per Share | 1.931 |
| Total Debt | 129,100,000 |
| Total Revenue | 701,200,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.57 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 12.50995 |
| Two Hundred Day Average Change | 12.110051 |
| Two Hundred Day Average Change Percent | 0.96803355 |
| Type Disp | Equity |
| Volume | 1,333,826 |
| Website | https://avanos.com |
| Zip | 30,004 |